Pediatrics Doctors in Newton Centre, MA Accepting Medicare

6 Pediatrics doctors found. Showing 1 - 6

Dr. Julie Beth Dollinger, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 32 Union St, Newton Centre, MA 02459 Phone: 617-209-3933

Carol P Podolsky, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Newton Health And Human Services, 1294 Centre Street, Newton Centre, MA 02459 Phone: 617-796-1420

Dr. Elissa B Rottenberg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1400 Centre St, Suite 203, Newton Centre, MA 02459 Phone: 617-244-9929    Fax: 617-244-9935

Dr. Wanessa P Risko, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 32 Union St, Newton Centre, MA 02459 Phone: 617-564-0123    Fax: 617-467-5318

Dr. Jonathan A Benjamin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1400 Centre St, Suite 203, Newton Centre, MA 02459 Phone: 617-244-9929    Fax: 617-244-9935

Dr. Roger W Spingarn, MD Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 Centre St, Suite 203, Newton Centre, MA 02459 Phone: 617-244-9929    Fax: 617-244-9935

News Archive

Study: Ultrasound waves applied to specific areas of brain appear to alter patients' moods

University of Arizona researchers have found in a recent study that ultrasound waves applied to specific areas of the brain appear able to alter patients' moods. The discovery has led the scientists to conduct further investigations with the hope that this technique could one day be used to treat conditions such as depression and anxiety.

Cavitation dose painting technique: A new method for precise drug delivery

If traditional drug delivery were a type of painting, it might be akin to paintball. With good aim, a majority of the paint ends on the bullseye, but it also drips and splashes, carrying streams of paint across the target.

Familial factors drive link between surroundings and schizophrenia risk

Associations between population density, neighbourhood deprivation and the risk of developing schizophrenia or depression can be attributed to familial selection factors rather than the local environment itself, research suggests.

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.

Read more Medical News

› Verified 2 days ago